Latest / Oncology Data Advisor
The Future of MRD in Multiple Myeloma Treatment Decision Making
In this interview, Oncology Data Advisor Editorial Board member Dr. Rahul Banerjee speaks with Dr. Ben Derman, Assistant Professor of Medicine at the University of Chicago, about his research regarding measurable residual disease (MRD) detection in multiple myeloma and its potential role in guiding treatment decisions.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.